🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 492327101
- IPO
- 4/8/2020 · $16.00/share
Business: Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with high unmet medical need.
Company Contact
- CEO
- Jasbir Seehra
- CFO
- Keith Regnante
- Headquarters
- 99 Hayden Avenue, Suite 120, Building E, Lexington, MA 02421
- Phone
- 617-314-6297
- Investor Relations
- Julia Balanova, Solebury Trout · 646-378-2936 · jbalanova@soleburytrout.com